NCT00051389View on ClinicalTrials.gov

ACE Inhibition and Novel Cardiovascular Risk Factors

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Cardiovascular DiseasesHeart DiseasesHypertension
Interventions
DRUG

Fosinopril

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00051389 - ACE Inhibition and Novel Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter